16:22 EDT Pharvaris files automatic mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHVS:
- Pharvaris N.V.’s High-Stakes Gamble: Navigating Clinical Trials and Regulatory Hurdles for Market Success
- Pharvaris price target raised to $50 from $49 at JMP Securities
- Pharvaris Excels in HAE Treatment Advances
- Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Pharvaris reports Q4 EPS (EUR 0.74) vs. (EUR 1.16) last year